atai Life Sciences (ATAI) announced topline results from Beckley Psytech’s Phase 2a open-label study of BPL-003 in 12 patients with moderate to severe alcohol use disorder. BPL-003 is a patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback